erythromycin has been researched along with Airflow Obstruction, Chronic in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (31.03) | 29.6817 |
| 2010's | 19 (65.52) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| He, Z; Huan, M; Huo, J; Li, M; Luo, Z; Ma, N; Qiu, J; Tang, X; Wang, S; Wei, Y; Wen, M; Zhong, X | 1 |
| Bai, J; Deng, JM; He, ZY; Li, MH; Liang, Y; Qiu, SL; Tang, QY; Zhang, H; Zhang, JQ; Zhong, XN; Zhou, X | 1 |
| Lyon, C; Nashelsky, J; Radi, R; Staff, T | 1 |
| Bahar, MA; Hak, E; Kocks, JWH; Wang, Y; Wilffert, B; Zijp, TR | 1 |
| Herath, SC; Maisey, S; Normansell, R; Poole, P | 1 |
| Jersild Jespersen, M; Mygind, LH; Sonne, J; Vestbo, J | 1 |
| Donaldson, GC; James, GD; Nazareth, I; Petersen, I; Wedzicha, JA | 1 |
| Herath, SC; Poole, P | 1 |
| Criner, GJ; Ramos, FL | 1 |
| Hofmann, T; Scheuch, G; Siekmeier, R | 1 |
| Bai, J; Deng, JM; He, ZY; Li, MH; Li, ZH; Liu, GN; MacNee, W; Sun, XJ; Zhang, JQ; Zhang, Y; Zhong, XN; Zhou, G | 1 |
| Akagawa, KS; Hanaki, H; Hirose, T; Matsui, H; Nakano, H; Ōmura, S; Shima, H; Sueki, A; Sugawara, A; Sunazuka, T | 1 |
| Bai, J; He, Z; Huang, H; Tan, C; Zhang, J; Zhong, X | 1 |
| Yamaya, M | 1 |
| Hurst, JR; Perera, WR; Sapsford, RJ; Seemungal, TA; Wedzicha, JA; Wilkinson, TM | 1 |
| Kunisaki, KM; Niewoehner, DE | 1 |
| Fukuchi, Y; Ichinose, M; Kudo, S; Seemungal, TA; Yamatani, M | 1 |
| Bai, J; Deng, JM; He, ZY; Li, MH; Liu, GN; MacNee, W; Ou, LM; Zhang, JQ; Zhong, XN | 1 |
| Duranti, R | 1 |
| Anić-Milić, T; Bogdan, M; Bosnar, M; Culić, O; Eraković Haber, V; Marjanović, N; Michielin, F; Parnham, MJ; Popović-Grle, S; Willé, DR | 1 |
| He, BM; Luo, BL; Yuan, H | 1 |
| Kuang, W; Liu, L; Tan, X; Wan, L; Zhou, Y | 1 |
| Decramer, M; Laekeman, G; Simoens, S | 1 |
| Castaldo, RS; Celli, BR; Gomez, F; Hanrahan, JP; LaVallee, N; Souhrada, J | 1 |
| Inoue, D; Sasaki, A; Sasaki, H; Suzuki, T; Yamatani, M; Yasuda, H | 1 |
| Bai, J; Feng, ZB; Liang, GR; Shi, HZ; Wu, C; Zhong, XN | 1 |
| Liu, J; Lu, XY; Shen, HH; Wu, DQ | 1 |
| Azuma, A | 1 |
9 review(s) available for erythromycin and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Bacterial Infections; Disease Progression; Erythromycin; Hospitalization; Humans; Outcome Assessment, Health Care; Pulmonary Disease, Chronic Obstructive; Quality of Life; Randomized Controlled Trials as Topic | 2018 |
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Disease Progression; Drug Administration Schedule; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic; Roxithromycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
[Sparse effect of long-term treatment with macrolides in patients with chronic obstructive pulmonary disease].
Topics: Anti-Bacterial Agents; Erythromycin; Evidence-Based Medicine; Humans; Long-Term Care; Macrolides; Pulmonary Disease, Chronic Obstructive; Radiography; Time; Treatment Outcome | 2013 |
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Disease Progression; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic | 2013 |
Use of long-term macrolide therapy in chronic obstructive pulmonary disease.
Topics: Anti-Bacterial Agents; Azithromycin; Cost-Benefit Analysis; Disease Progression; Drug Administration Schedule; Drug Resistance, Bacterial; Erythromycin; Humans; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Sputum; Time Factors; Treatment Outcome | 2014 |
Inhalation of macrolides: a novel approach to treatment of pulmonary infections.
Topics: Administration, Inhalation; Aerosols; Animals; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Clarithromycin; Cystic Fibrosis; Erythromycin; Humans; Ketolides; Lung; Macrolides; Pulmonary Disease, Chronic Obstructive; Rats | 2015 |
[Effects of mucolytic agents and macrolides in the treatment of COPD].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Antiviral Agents; Clarithromycin; Disease Progression; Drug Therapy, Combination; Erythromycin; Expectorants; Goblet Cells; Humans; Hyperplasia; Macrolides; Mucins; Mucociliary Clearance; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Retrospective Studies; Treatment Outcome | 2016 |
Preventing COPD exacerbations with macrolides: a review and budget impact analysis.
Topics: Anti-Bacterial Agents; Azithromycin; Belgium; Clarithromycin; Drug Costs; Erythromycin; Health Care Costs; Humans; Macrolides; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2013 |
[Therapeutic efficacy of macrolide anti-infective agents and other pharmacological actions].
Topics: Anti-Infective Agents; Asthma; Azithromycin; Bronchiolitis; Chronic Disease; Clinical Trials as Topic; Cystic Fibrosis; Erythromycin; Gene Expression Regulation, Bacterial; Humans; Macrolides; Mucins; Neutrophils; Pancreatic Elastase; Pseudomonas aeruginosa; Pulmonary Disease, Chronic Obstructive; Respiratory Mucosa; Sinusitis; Structure-Activity Relationship | 2005 |
5 trial(s) available for erythromycin and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Effects of Low-Dose and Long-Term Treatment with Erythromycin on Interleukin-17 and Interleukin-23 in Peripheral Blood and Induced Sputum in Patients with Stable Chronic Obstructive Pulmonary Disease.
Topics: Aged; Enzyme-Linked Immunosorbent Assay; Erythromycin; Humans; Interleukin-17; Interleukin-23; Middle Aged; Pulmonary Disease, Chronic Obstructive; Sputum; Walking | 2016 |
Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations.
Topics: Aged; Antibiotic Prophylaxis; Double-Blind Method; Erythromycin; Female; Forced Expiratory Volume; Humans; Inflammation; Kaplan-Meier Estimate; Macrolides; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Sputum | 2008 |
Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease.
Topics: Aged; Anti-Bacterial Agents; Double-Blind Method; Erythromycin; Female; Humans; Leukocyte Count; Leukocyte Elastase; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life; Sputum; Treatment Outcome | 2010 |
A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Azithromycin; Drug Administration Schedule; Erythromycin; Female; Humans; Macrolides; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Single-Blind Method; Time Factors; Treatment Outcome | 2003 |
[Suppression of rhinovirus infections with macrolide antibiotics].
Topics: Aged; Cells, Cultured; Common Cold; Epithelial Cells; Erythromycin; Female; Humans; Intercellular Adhesion Molecule-1; Male; Pulmonary Disease, Chronic Obstructive; Receptors, LDL; Receptors, Virus; Rhinovirus; RNA, Viral; Trachea; Virus Replication | 2003 |
15 other study(ies) available for erythromycin and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Effect of erythromycin on the ultrastructure of human macrophages exposed to cigarette smoke extract
Topics: Cigarette Smoking; Erythromycin; Humans; Macrophages; Nicotiana; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species | 2022 |
Erythromycin suppresses neutrophil extracellular traps in smoking-related chronic pulmonary inflammation.
Topics: Animals; B7-2 Antigen; CD40 Antigens; Cigarette Smoking; Dendritic Cells; Erythromycin; Extracellular Traps; Fluorescent Antibody Technique; Humans; Inflammation; Male; Mice; Mice, Inbred C57BL; Neutrophils; Pulmonary Disease, Chronic Obstructive; Th1 Cells; Th17 Cells | 2019 |
Clinical Inquiries: Does prophylactic azithromycin reduce the number of COPD exacerbations or hospitalizations?
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Erythromycin; Female; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive | 2018 |
Use of long-term antibiotic treatment in COPD patients in the UK: a retrospective cohort study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cohort Studies; Disease Progression; Doxycycline; Erythromycin; Female; Humans; Longitudinal Studies; Male; Middle Aged; Oxytetracycline; Penicillins; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Sex Factors; United Kingdom | 2013 |
Combination of erythromycin and dexamethasone improves corticosteroid sensitivity induced by CSE through inhibiting PI3K-δ/Akt pathway and increasing GR expression.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Blotting, Western; Case-Control Studies; Dexamethasone; Drug Therapy, Combination; Erythromycin; Gastrointestinal Agents; Histone Deacetylase 2; Humans; Interleukin-8; Leukocytes, Mononuclear; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Receptors, Glucocorticoid; Smoking; U937 Cells | 2015 |
Non-antibiotic 12-membered macrolides: design, synthesis and biological evaluation in a cigarette-smoking model.
Topics: Animals; Anti-Inflammatory Agents; Cell Differentiation; Cell Line; Disease Models, Animal; Erythromycin; Guinea Pigs; Lung; Macrolides; Macrophages; Microbial Sensitivity Tests; Monocytes; Pulmonary Disease, Chronic Obstructive; Smoking | 2016 |
Antibiotic prophylaxis for chronic obstructive pulmonary disease: resurrecting an old idea.
Topics: Antibiotic Prophylaxis; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic | 2008 |
[Potential role of macrolides in the treatment of COPD: current evidence. (discussion)].
Topics: Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Cytokines; Depression, Chemical; Erythromycin; Humans; Immunologic Factors; Inflammation Mediators; Macrolides; Pulmonary Disease, Chronic Obstructive; Receptors, Virus; Risk Assessment | 2009 |
Long-term treatment with macrolides - light in the darkness of COPD therapy?
Topics: Anti-Bacterial Agents; Erythromycin; Humans; Pulmonary Disease, Chronic Obstructive | 2010 |
Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Survival; Cells, Cultured; Chemokines; Clarithromycin; Cytokines; Erythromycin; Humans; Macrolides; Pulmonary Disease, Chronic Obstructive; Roxithromycin; Sputum | 2011 |
[The effect of erythromycin on transforming growth factor-β(1) and secretory leukocyte proteinase inhibitor in a rat model of chronic obstructive pulmonary disease].
Topics: Animals; Bronchi; Erythromycin; Lung; Male; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Secretory Leukocyte Peptidase Inhibitor; Transforming Growth Factor beta1 | 2011 |
Erythromycin ameliorates cigarette-smoke-induced emphysema and inflammation in rats.
Topics: Animals; Apoptosis; Disease Models, Animal; Erythromycin; Humans; Interleukin-10; Male; Matrix Metalloproteinase 9; Nicotiana; Pneumonia; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Rats; Rats, Sprague-Dawley; Smoke; Smoking; Tissue Inhibitor of Metalloproteinase-1; Translational Research, Biomedical; Tumor Necrosis Factor-alpha | 2012 |
[An experimental study on airway inflammation and remodeling in a rat model of chronic bronchitis and emphysema].
Topics: Animals; Anti-Bacterial Agents; Bronchitis, Chronic; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Erythromycin; Hyaluronic Acid; Male; Muscle, Smooth, Vascular; Procollagen; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Radioimmunoassay; Rats; Rats, Wistar; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
[Equally whether the child's lung or chronically inflamed bronchi. Acute bacterial infections have to be terminated fast].
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bronchitis, Chronic; Child; Clinical Trials as Topic; Double-Blind Method; Erythromycin; Humans; Middle Aged; Multicenter Studies as Topic; Ofloxacin; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Radiography, Thoracic; Randomized Controlled Trials as Topic; Time Factors | 2004 |
[The expression of transforming growth factor beta-1 in rat model of chronic obstructive pulmonary disease and the effects of early drugs intervention].
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Budesonide; Drugs, Chinese Herbal; Erythromycin; Male; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |